CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Viridian Therapeutics prices upsized $350M concurrent stock, and convertible notes offerings

Neutral
AI Analysis

Summary

Viridian Therapeutics priced an upsized $350M concurrent offering consisting of common stock and convertible notes.

Importance:6/10
Sentiment:
0.00
capital_raiseconcurrent_offeringconvertible_notesstock_offering

Read the original article

Published by Seeking Alpha Healthcare on May 7, 2026 5:36 AM

Read Original